[go: up one dir, main page]

NO20005223D0 - Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen - Google Patents

Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen

Info

Publication number
NO20005223D0
NO20005223D0 NO20005223A NO20005223A NO20005223D0 NO 20005223 D0 NO20005223 D0 NO 20005223D0 NO 20005223 A NO20005223 A NO 20005223A NO 20005223 A NO20005223 A NO 20005223A NO 20005223 D0 NO20005223 D0 NO 20005223D0
Authority
NO
Norway
Prior art keywords
acetylglucosamine
colon
administration
treatment
composition
Prior art date
Application number
NO20005223A
Other languages
English (en)
Other versions
NO20005223L (no
Inventor
Simon Murch
Ian W French
Original Assignee
Glucogenics Pharmaceuticals In
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA1999/000218 external-priority patent/WO1999053929A1/en
Application filed by Glucogenics Pharmaceuticals In filed Critical Glucogenics Pharmaceuticals In
Publication of NO20005223D0 publication Critical patent/NO20005223D0/no
Publication of NO20005223L publication Critical patent/NO20005223L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/02—Suppositories; Bougies; Bases therefor; Ovules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Nutrition Science (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20005223A 1998-04-17 2000-10-17 Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen NO20005223L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CA002234936A CA2234936C (en) 1998-04-17 1998-04-17 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine
PCT/CA1999/000218 WO1999053929A1 (en) 1998-04-17 1999-03-12 Composition for and treatment of inflammatory bowel disease by colon administration of n-acetylglucosamine

Publications (2)

Publication Number Publication Date
NO20005223D0 true NO20005223D0 (no) 2000-10-17
NO20005223L NO20005223L (no) 2000-11-20

Family

ID=4162337

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20005223A NO20005223L (no) 1998-04-17 2000-10-17 Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen

Country Status (8)

Country Link
EP (1) EP1071432A1 (no)
JP (1) JP2002512195A (no)
CA (1) CA2234936C (no)
CZ (1) CZ20003846A3 (no)
HU (1) HUP0101514A3 (no)
IL (1) IL139072A0 (no)
NO (1) NO20005223L (no)
PL (1) PL343634A1 (no)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2621018T3 (es) 2007-02-19 2017-06-30 Marine Polymer Technologies, Inc. Composiciones hemostáticas y regímenes terapéuticos
KR101098581B1 (ko) * 2009-01-09 2011-12-26 서울대학교산학협력단 Ａｂｈ 항원을 이용한 염증질환 개선용 조성물
CN103108638B (zh) 2010-04-15 2016-11-09 海洋聚合物技术公司 聚-n-乙酰葡萄糖胺纳米纤维的抗菌应用
WO2012142581A1 (en) 2011-04-15 2012-10-18 Marine Polymer Technologies, Inc. Treatment of disease with poly-n-acety glucosamine nanofibers
WO2014142938A1 (en) * 2013-03-15 2014-09-18 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
US9539265B2 (en) 2013-03-15 2017-01-10 Aihol Corporation Pharmaceutical formulation containing glycosaminoglycan
HUE049247T2 (hu) * 2014-11-26 2020-09-28 Evonik Operations Gmbh Etanol hatásával szemben ellenálló gyógyászati vagy táplálék-gyógyszerészeti kompozíció
KR102104507B1 (ko) * 2019-08-23 2020-04-24 브릿지바이오테라퓨틱스(주) 팔미토일-l-프롤릴-l-프롤릴-글리실-l-타이로신 나트륨을 포함하는 약제학적 제제 및 이의 제조방법

Also Published As

Publication number Publication date
IL139072A0 (en) 2001-11-25
JP2002512195A (ja) 2002-04-23
HUP0101514A3 (en) 2003-07-28
NO20005223L (no) 2000-11-20
EP1071432A1 (en) 2001-01-31
CA2234936C (en) 2004-06-29
CA2234936A1 (en) 1999-10-17
PL343634A1 (en) 2001-08-27
HUP0101514A2 (hu) 2001-11-28
CZ20003846A3 (cs) 2002-03-13

Similar Documents

Publication Publication Date Title
IL132145A (en) Compositions for treating inflammatory bowel disease and uses thereof
NO20022974L (no) Anvendelse av biologisk aktive vitamin D-forbindelser for forhindring og behandling av inflammatorisk tarmsykdom
IL245956A0 (en) Novel immunogenic compositions for the prevention and treatment of meningococcal disease
HUP0104867A3 (en) Heterocyclic compounds useful in the treatment of inflammatory diseases, process for their preparation, pharmaceutical compositions comprising thereof and their use
NO994256D0 (no) SmÕ molekyler som er anvendelige ved behandling av inflamasjonssykdom
WO2003034984A9 (en) Compositions and methods for the diagnosis and treatment of inflammatory bowel disorders
NO20016427L (no) Blandinger og fremgangsmåter for behandling av diagnose av lungekreft
FI965154L (fi) Lääkkeen paksusuoleen kuljettava koostumus
NO20006630D0 (no) Farmasöytisk sammensetning for behandlingen av diabetes
NO993979D0 (no) FremgangsmÕte for Õ forhindre og forsinke starten pÕ Alzheimer's sykdom og sammensetning derfor
DK1141235T3 (da) Bifidobakterier til behandling af inflammatorisk sygdom
IL151345A0 (en) Method for treating inflammatory bowel disease and other forms of gastrointestinal inflammation
KR970000230A (ko) 염증성 장 질환을 치료하기 위한 캅파-아편제 작용물질
ZA988920B (en) Pharmaceutical composition for the treatment of inflammatory bowel disease and irritable bowel syndrome
DE69919179D1 (de) Substituierte gamma-phenyl-delta-lactone und deren analoge, und ihre verwendungen
AU2002246519A8 (en) Compositions and methods for the therapy and diagnosis of colon cancer
ID27576A (id) Penggunaan siklosporin dalam pengobatan penyakit-penyakit peradangan autoimun
NO20001412D0 (no) Sammensetninger og fremgangsmåter ved behandling av respiratoriske forstyrrelser
AU6386499A (en) Method and composition for treatment of inflammatory bowel disease
EP1085906A4 (en) ANTIBODIES AGAINST CYTOKINS FOR THE PREVENTION AND TREATMENT OF INFLAMMABLE INTESTINAL DISEASES
NO20005223D0 (no) Sammensetning for og behandling av inflammatrisk tarmsykdom ved administrering av N-acetylglucosamin i tykktarmen
IT1303805B1 (it) Cotile da revisione per impiego nel trattamento di patologiedell'anca.
IL155174A0 (en) Methods and compositions for the treatment of inflammatory diseases
AU2001257406A1 (en) Methods and compositions for the diagnosis and treatment of cardiovascular and tumorigenic disease using 4941
ITMI20010957A0 (it) Derivati dell'aoe-emodina e loro impiego nel trattamento di patologieneoplastiche

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application